Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.3 EUR | 0.00% | 0.00% | 0.00% |
Mar. 18 | ASR Nederland N.V.(ENXTAM:ASRNL) added to S&P International 700 | CI |
Mar. 18 | ASR Nederland N.V.(ENXTAM:ASRNL) added to S&P EUROPE 350 - Insurance (Industry Group) | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- For the last few months, analysts have been revising downwards their earnings forecast.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 10B | - | ||
+17.91% | 112B | C+ | ||
+7.17% | 108B | B- | ||
+13.47% | 106B | B | ||
+9.85% | 78.57B | C+ | ||
+29.00% | 30.67B | A- | ||
+14.93% | 20.67B | A- | ||
-2.79% | 11.78B | B- | ||
+5.54% | 10.65B | A- | ||
+23.71% | 10.31B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ASRNL Stock
- 0RHS Stock
- Ratings ASR Nederland